Heart Disease Trial, Recruiting (NCT07537296)

Heart Disease Trial, Recruiting NCT07537296 Sponsor: Nanjing First Hospital, Nanjing Medical University Condition: Heart Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07537296 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Heart Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are 18 years of age or older
People who have had a heart attack within the last 4 weeks, including either a major type (called STEMI) or a less severe type (called NSTEMI)
People who have had a procedure to open a blocked heart artery (called PCI) as treatment for their heart attack, performed according to current medical guidelines
People whose condition is currently stable, with no signs of serious circulation problems
People willing to have a specialised heart scan (cardiac CT) within 7 days after their artery-opening procedure
People willing to take part in follow-up phone calls as part of the study

Who may not be able to join:

People whose kidneys are not working well enough for a contrast dye scan, or who have an allergy to iodine-based dye used in CT scans
People who have previously had open-heart bypass surgery on their heart arteries
People with a history of heart failure or a previous heart attack (before the current one)
People with a serious irregular heartbeat or a significant structural problem with their heart
People whose scan images turn out to be unclear or unusable (confirm with trial site)
People whose overall health means they are not expected to survive beyond 6 months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07537296

Sponsor: Nanjing First Hospital, Nanjing Medical University

Phase: Not Applicable

Status: Recruiting

Condition: Heart Disease

More information: https://clinicaltrials.gov/study/NCT07537296

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are 18 years of age or older
People who have had a heart attack within the last 4 weeks, including either a major type (called STEMI) or a less severe type (called NSTEMI)
People who have had a procedure to open a blocked heart artery (called PCI) as treatment for their heart attack, performed according to current medical guidelines
People whose condition is currently stable, with no signs of serious circulation problems
People willing to have a specialised heart scan (cardiac CT) within 7 days after their artery-opening procedure
People willing to take part in follow-up phone calls as part of the study

Who may not be able to join:

People whose kidneys are not working well enough for a contrast dye scan, or who have an allergy to iodine-based dye used in CT scans
People who have previously had open-heart bypass surgery on their heart arteries
People with a history of heart failure or a previous heart attack (before the current one)
People with a serious irregular heartbeat or a significant structural problem with their heart
People whose scan images turn out to be unclear or unusable (confirm with trial site)
People whose overall health means they are not expected to survive beyond 6 months

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Nanjing First Hospital, Nanjing Medical University

Registry

ClinicalTrials.gov

Start date

1 January 2026

Est. completion

31 December 2030

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Thrombotic events

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov